Earnings calls / FSL · August 6, 2026

Firstsource Solutions Ltd Q1 FY27 Earnings Call Summary

Firstsource Q1 FY27 revenue was ₹27.2 billion, up 12.3% YoY in constant currency, with EBIT margin 12.4% and adjusted PAT ₹2.2 billion, up 31.2% YoY. The driver was best-in-four-quarter ACV intake of four large deals and 12 new logos, offsetting a healthcare BPAS engagement wind-down after a client leadership change. Management reaffirmed FY27 guidance of 10%-13% constant currency revenue growth and 12.25%-12.75% EBIT margin, expecting stronger H2 as new deals ramp. Main risks are the ₹271 million net exceptional charge from that wind-down plus a separate ₹216 million regulatory settlement, with recovery and healthcare payer recalibration uncertain.

Revenue
Margin
Demand
Guidance
Tone

Event Participants

Executives

2 Dinesh Jain, Ritesh Idnani

Analysts

4 Dipesh Mehta, Girish Pai, Vamshi Krishna, Vibhor Singhal

Financials & KPIs

Metric Reported Commentary
Revenue ₹27.2 billion +22.9% YoY, +5.5% QoQ; 9th straight quarter of double-digit YoY growth
Revenue (USD) $288 million +11.2% YoY, +1.8% QoQ; crossed $1 billion annual run-rate
Revenue (Constant Currency) +12.3% YoY, +2.2% QoQ; 11th straight sequential growth quarter
EBIT ₹3,367 million +34.8% YoY; margin 12.4%, up 110 bps YoY, 20 bps QoQ
EBIT Margin 12.4% 7th straight quarter of margin expansion; from 11% eight quarters ago
Adjusted Net Profit ₹2.2 billion +31.2% YoY, +8.3% QoQ; 8.2% of revenue
Reported PAT ₹1.7 billion After exceptional charge of ₹717 million (₹563 million net of tax)
Diluted EPS ₹2.36 Adjusted EPS basis
Headcount 36,875 Net add of 670 over Q4 FY26; offshore/nearshore ~80% of gross additions
Voluntary Attrition 27.5% Quarterly rate
Cash & Bank Balances ₹3 billion
Net Debt ₹17.1 billion vs ₹16.3 billion at end of March 2026
DSO (Normalized) 67-69 days Consistent with prior quarters
FCF to PAT (Normalized) 94% Adjusted for subsequent collections on exceptional account
Effective Tax Rate ~23% FY27 expected 22%-24% after moving to new tax regime in India
Hedge Book - GBP £61.6 million 12-month coverage; average rate ₹118-120
Hedge Book - USD $119 million 12-month coverage; average rate ₹92.7

Table Rules:

  • Order metrics logically: Deposits → Assets → Asset Quality → Profitability → Margins → Capital
  • Always include units (₹ crores, %, bps, count)
  • Commentary: YoY/QoQ changes first, then brief context/driver
  • Use "+/-" for changes, "bps" for basis points
  • Be precise: "₹2.69 lakh crores" not "2.69L cr"

Geographic & Segment Commentary

Banking & Financial Services (BFS): Grew 14% YoY, 5% QoQ in constant currency. Added 5 new logos; strong client interest in intelligent operations, financial crime, compliance, and collections. Collections demand strong amid record U.S. consumer debt; mortgage clients focused on cost takeout due to high rates. Q1 exit pipeline amongst strongest in recent quarters.

Healthcare: Revenues grew 11% YoY but declined 2% QoQ in constant currency. Added 4 new logos. Payer side faced program timing effects from Medicare Advantage clients recalibrating scope due to CMS rate adjustments. One transformative BPAS engagement wound down following client leadership change. AI-first approach now standard across eligibility, early out, and denials platforms.

Communications, Media & Technology (CMT): Grew 6% YoY and 9% QoQ; added 2 new logos. Volatility from timing of work packets and program transitions in Silicon Valley consumer tech engagements. Telecom/cable clients exploring AI-led improvements; early adoption of domain harness approach.

Diverse Portfolio (Utilities, Retail, etc.): Grew 27% YoY, flat QoQ in constant currency; added 1 new logo. Utilities demand steady with healthy pipeline; Pastdue Credit strengthening U.K. utilities ecosystem with cross-sell from 2 clients. Retail demand centered on CX improvement, cost reduction, and personalized interactions.

North America: 8% YoY growth, flat QoQ in constant currency. Broad-based momentum across three core verticals; incubating growth via Canada sales presence and replicating U.K. capabilities (utilities, retail) into U.S.

Europe: Strong quarter with 18% YoY, 6% QoQ in constant currency. Won 2 large deals; pipeline building well. South Africa fastest growing geography with strong nearshore pitch. New Glasgow office for financial services regulatory work.

Australia: Revenue doubled YoY from additional business with existing clients and new logos; building strong pipeline.

Company-Specific & Strategic Commentary

Kairos AI-Native Operating System: Took to clients across geos focused on moving from AI experimentation to real operational change. MLM (mortgage language model) deployed across mortgage clients, handling 200+ document ingestion scenarios. AI platforms now live for 14 of top 20 U.S. mortgage lenders, 10 of top 15 U.S. health plans, and top 5 U.S. and U.K. card issuers.

Partner Ecosystem Expansion: Deepened hyperscaler collaboration (AWS, Google Cloud). Announced partnerships with Zendesk (vertical-specific AI-native solutions starting with retail), Cresta (dedicated AI center of excellence), and Silicon Valley startups (targeted investments in intelligent context framework). 6th consecutive quarter of 4+ large deal wins; Q1 ACV intake highest in last 4 quarters.

Intelligence That Operates - Internal Execution: Rolled out early engagement framework with real-time attrition risk console. AI embedded across people operations. Recognized by Everest Group as major contender in RCM Intelligent Operations PEAK Matrix 2026; ISG placed company in Breakthrough 15 ($1-3 billion tier) after crossing $1 billion revenue.

Client Basing Strategy: 145 clients generating $1M+ revenue run-rate. $5M+ clients up 80% over past two years; $1M+ clients up 45%. Top 5 and top 10 client revenue share declined over last 8 quarters even as top clients grew.

New Growth Engines: Stood up 5 growth engines (Middle East, South Africa, Canada) and 3 capability frontiers (U.S. retail/CPG practice, marketing services, security & resiliency services), each with dedicated leadership.

Guidance & Outlook

Metric Guidance / Outlook Commentary
Revenue Growth (Constant Currency) 10%-13% for FY27 Reaffirmed despite ~1%-1.5% impact from BPAS program wind-down; offset by strong Q1 deal wins (best in 4 quarters) and ramping pipeline
EBIT Margin 12.25%-12.75% for FY27 Reaffirmed; Q1 at 12.4% already above lower end; seventh consecutive quarter of margin expansion
Long-term EBIT Margin 14%-15% band over 2-3 years Management remains focused on this trajectory
Effective Tax Rate 22%-24% for FY27 New tax regime in India allows MAT credit draw-down
Revenue Trajectory H2 FY27 expected stronger New wins need 3 months to ramp; second half expected stronger as conversions and ramps play out

Risks & Constraints

Risk Context
Healthcare BPAS Program Termination Client leadership change led to winding down of transformative engagement; ~1%-1.5% FY27 growth impact. Management maintains relationship continues with client still strategic ($5M+ annual revenue); exceptional charge of ₹271 million net of tax taken on prudence basis with recovery being pursued.
Regulatory Penalty Indemnification One-time settlement of commercial dispute in healthcare operations from prior-period claims processing issue; ₹216 million net of tax charged; insurance claim filed with optimistic recovery outlook; client continues expanding business with Firstsource.
Healthcare Payer Regulatory Pressure CMS rate adjustments and evolving utilization management requirements causing program scope recalibration by Medicare Advantage clients; management frames as pacing effect, not demand shift; regulatory friction making outcome-accountable partnerships structurally more valuable.
CMT Vertical Volatility Inherent volatility from timing of work packets and program transitions in Silicon Valley consumer tech engagements; management expects return to healthier growth as transitions complete and volumes normalize.
Currency Risk GBP hedge book rate ₹118-120 vs current market ~₹123-124; option products on 25%-30% of portfolio provide upside protection; USD hedged at ₹92.7-94 vs market ~₹94 average.
Program Ramp Costs New transformative deals ramp in phases, converting revenue over extended periods; cost of growth may temporarily dilute segment margins, though company-level margins continue expanding.

Q&A Highlights

Healthcare BPAS Termination Details

  • Question: What was the impact of the project termination on this quarter's revenue, and does the ₹271 million charge include unbilled revenue reversals? How recoverable is it? (Vibhor Singhal)
  • Answer: The wind-down follows a client leadership change and the decision to maintain status quo with existing technology rather than proceed with transformation. Delivery had been strong; client remains a strategic logo with $5M+ annual revenue and added more work in the last month. The charge relates to partner ecosystem obligations where Firstsource was single point of accountability; recovery discussions constructive. Q1 revenue impact ~1%-1.5%. (Ritesh Idnani)

Guidance Sustainability Post-Termination

  • Question: Does maintaining guidance mean the company will exit at midpoint rather than top end? Is the pipeline strong enough to offset the impact? (Vibhor Singhal)
  • Answer: Q1 was the best quarter in last four in terms of pipeline wins; several deals ramping quickly which offsets the 1%-1.5% impact. Pipeline remains healthy despite deal wins, giving comfort to reinforce guidance. (Ritesh Idnani)

Isolation of One-Offs

  • Question: Should this be read as an isolated incident or a signal of broader healthcare sector challenges from regulatory pressure? (Vibhor Singhal)
  • Answer: Far from it, actually the contrary. Client relationships continue expanding; this was an isolated one-off from a leadership change where new leaders naturally pause programs. Healthcare still generates a third of deal wins, matching its revenue share. Nothing secular here. (Ritesh Idnani)

Exceptional Items - Same or Different Clients

  • Question: Do the first two exceptional items reflect the same or different clients? And what happens to the originally expected ramp toward steady state? (Dipesh Mehta)
  • Answer: The two items pertain to different clients. The second is a one-time settlement of a commercial dispute in healthcare operations from a prior-period claims processing issue, since remediated, with insurance recovery being pursued. That client also continues expanding business. On ramp expectations, 1%-1.5% was what was expected for this fiscal year from that specific program, not the full steady-state. (Ritesh Idnani)

Revenue Recognition and Collections

  • Question: Has revenue booked in prior periods been fully collected, or is there reversal risk from the termination? (Dipesh Mehta)
  • Answer: All revenue accounted for has been received or will be received in normal course; first phase of resolution already collected. The provision relates to partner-related payments where third-party obligations may face challenges, but contractually recoverable. Conservative accounting requires provisioning given uncertainty. (Dinesh Jain)

Segment Margin Divergence

  • Question: Why have segment margins shifted materially (BFS up to 20%+, healthcare down to low double digits) over the past 2.5 years? Will they normalize? (Dipesh Mehta)
  • Answer: Don't read too much into quarterly segment variations; ramp-up costs in a particular quarter dilute margins but trend upward afterward. Nothing systemic. Company margins have expanded for seven straight quarters from 11% to 12.4%. The 50-75 bps annual margin expansion thesis continues to hold. (Ritesh Idnani)

Exceptional Items and Industry Transition

  • Question: Given the industry shift toward outcome-based models, should we expect more delivery disconnects during this transition? (Vamshi Krishna)
  • Answer: Domain orientation is a prerequisite for nonlinear commercial models. Players who don't know processes at second/third level of detail will struggle. Occasional errors are the nature of the beast; key is having controls commensurate with risk. This is a one-off, evidenced by continued client expansion. (Ritesh Idnani)

Hedge Book Details

  • Question: What is the current hedge liability position and how does it play out over the next 3-4 quarters? (Vamshi Krishna)
  • Answer: GBP book of £61.6 million for next 12 months at average rate ₹118-120; USD book of $119 million at ₹92.7. Option products covering 25%-30% of portfolio offer upside with no downside. Overall portfolio average rate approximately ₹123-124 for GBP and ₹94 for USD. (Dinesh Jain)

TAM Expansion Through Full-Stack Positioning

  • Question: Has the new full-stack intelligence operator positioning started showing up in TCV/pipeline? When will the 7x TAM opportunity reflect in growth? (Girish Pai)
  • Answer: Already playing out. New revenue streams emerging: marketing technology stack work, penetration/red team testing for agentic AI security, customer journey transformation using Kairos domain harness with process mining and task intelligence. Deal wins this quarter were best in five quarters; some new logos exceed $5M at outset with incumbent displacement. (Ritesh Idnani)

Revenue Growth Phasing

  • Question: Will revenue growth be smooth across next three quarters or bunched toward year-end? (Girish Pai)
  • Answer: New wins will take next ~3 months to continue ramping; expect H2 to be strong, consistent with ability to hit reaffirmed guidance. (Ritesh Idnani)

Key Takeaway

Firstsource delivered a robust Q1 FY27 with revenue of ₹27.2 billion, growing 12.3% YoY in constant currency (9th straight quarter of double-digit growth), EBIT margin of 12.4% (7th consecutive expansion quarter), and adjusted PAT of ₹2.2 billion (+31.2% YoY). The quarter featured best-in-four-quarter ACV intake with four large deals (6th straight quarter of 4+), 12 new logos including 3 strategic ones. However, healthcare saw a transformative BPAS engagement wound down after client leadership change, carrying ~1%-1.5% FY27 growth impact and a ₹271 million net-of-tax exceptional charge; a separate ₹216 million charge related to a regulatory penalty indemnification. Management reaffirmed FY27 guidance of 10%-13% constant currency growth and 12.25%-12.75% EBIT margin, offsetting the termination with strong new wins and a $1 billion+ pipeline. Strategy centers on Kairos AI-native operating system deployment across mortgage, healthcare, and collections platforms serving 14 of top 20 U.S. mortgage lenders and 10 of top 15 U.S. health plans, complemented by hyperscaler and vertical-specific partnerships (Zendesk, Cresta). Watch factors include healthcare payer regulatory recalibrations, CMT vertical volatility, and successful recovery of exceptional provisions, with long-term margin target of 14%-15% over 2-3 years.

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for every listed Indian company
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free